Metabolism of bile salts in mice influences spore germination in Clostridium difficile
- PMID: 20090901
- PMCID: PMC2806926
- DOI: 10.1371/journal.pone.0008740
Metabolism of bile salts in mice influences spore germination in Clostridium difficile
Abstract
Clostridium difficile, a spore-forming bacterium, causes antibiotic-associated diarrhea. In order to produce toxins and cause disease, C. difficile spores must germinate and grow out as vegetative cells in the host. Although a few compounds capable of germinating C. difficile spores in vitro have been identified, the in vivo signal(s) to which the spores respond were not previously known. Examination of intestinal and cecal extracts from untreated and antibiotic-treated mice revealed that extracts from the antibiotic-treated mice can stimulate colony formation from spores to greater levels. Treatment of these extracts with cholestyramine, a bile salt binding resin, severely decreased the ability of the extracts to stimulate colony formation from spores. This result, along with the facts that the germination factor is small, heat-stable, and water-soluble, support the idea that bile salts stimulate germination of C. difficile spores in vivo. All extracts able to stimulate high level of colony formation from spores had a higher proportion of primary to secondary bile salts than extracts that could not. In addition, cecal flora from antibiotic-treated mice was less able to modify the germinant taurocholate relative to flora from untreated mice, indicating that the population of bile salt modifying bacteria differed between the two groups. Taken together, these data suggest that an in vivo-produced compound, likely bile salts, stimulates colony formation from C. difficile spores and that levels of this compound are influenced by the commensal gastrointestinal flora.
Conflict of interest statement
Figures
Similar articles
-
Progesterone analogs influence germination of Clostridium sordellii and Clostridium difficile spores in vitro.J Bacteriol. 2011 Jun;193(11):2776-83. doi: 10.1128/JB.00058-11. Epub 2011 Apr 8. J Bacteriol. 2011. PMID: 21478359 Free PMC article.
-
Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions.mSphere. 2018 Sep 5;3(5):e00335-18. doi: 10.1128/mSphere.00335-18. mSphere. 2018. PMID: 30185513 Free PMC article.
-
Single-spore germination analyses reveal that calcium released during Clostridioides difficile germination functions in a feedforward loop.mSphere. 2023 Aug 24;8(4):e0000523. doi: 10.1128/msphere.00005-23. Epub 2023 Jun 20. mSphere. 2023. PMID: 37338207 Free PMC article.
-
A Revised Understanding of Clostridioides difficile Spore Germination.Trends Microbiol. 2020 Sep;28(9):744-752. doi: 10.1016/j.tim.2020.03.004. Epub 2020 Apr 23. Trends Microbiol. 2020. PMID: 32781028 Review.
-
Review and Commentary on the Importance of Bile Acids in the Life Cycle of Clostridioides difficile in Children and Adults.J Pediatric Infect Dis Soc. 2021 May 28;10(5):659-664. doi: 10.1093/jpids/piaa150. J Pediatric Infect Dis Soc. 2021. PMID: 33626138 Review.
Cited by
-
Reviewing the Clostridioides difficile Mouse Model: Insights into Infection Mechanisms.Microorganisms. 2024 Jan 27;12(2):273. doi: 10.3390/microorganisms12020273. Microorganisms. 2024. PMID: 38399676 Free PMC article. Review.
-
Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details.Infect Drug Resist. 2024 Feb 15;17:623-639. doi: 10.2147/IDR.S419243. eCollection 2024. Infect Drug Resist. 2024. PMID: 38375101 Free PMC article. Review.
-
Clostridioides difficile Sporulation.Adv Exp Med Biol. 2024;1435:273-314. doi: 10.1007/978-3-031-42108-2_13. Adv Exp Med Biol. 2024. PMID: 38175480 Review.
-
Clostridioides difficile infections; new treatments and future perspectives.Curr Opin Gastroenterol. 2024 Jan 1;40(1):7-13. doi: 10.1097/MOG.0000000000000989. Epub 2023 Nov 9. Curr Opin Gastroenterol. 2024. PMID: 37942659 Free PMC article. Review.
-
Correlating Antibiotic-Induced Dysbiosis to Clostridioides difficile Spore Germination and Host Susceptibility to Infection Using an Ex Vivo Assay.ACS Infect Dis. 2023 Oct 13;9(10):1878-1888. doi: 10.1021/acsinfecdis.3c00192. Epub 2023 Sep 27. ACS Infect Dis. 2023. PMID: 37756389
References
-
- Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis. 2007;45:222–227. - PubMed
-
- Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med. 2002;162:2177–2184. - PubMed
-
- O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007;28:1219–1227. - PubMed
-
- O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136:1913–1924. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
